GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » Gross Margin %

Godavari Drugs (BOM:530317) Gross Margin % : 20.38% (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Godavari Drugs's Gross Profit for the three months ended in Dec. 2023 was ₹88 Mil. Godavari Drugs's Revenue for the three months ended in Dec. 2023 was ₹431 Mil. Therefore, Godavari Drugs's Gross Margin % for the quarter that ended in Dec. 2023 was 20.38%.

Warning Sign:

Godavari Drugs Ltd gross margin has been in long-term decline. The average rate of decline per year is -3.6%.


The historical rank and industry rank for Godavari Drugs's Gross Margin % or its related term are showing as below:

BOM:530317' s Gross Margin % Range Over the Past 10 Years
Min: 12.64   Med: 21.65   Max: 87.88
Current: 21.53


During the past 13 years, the highest Gross Margin % of Godavari Drugs was 87.88%. The lowest was 12.64%. And the median was 21.65%.

BOM:530317's Gross Margin % is ranked worse than
86.41% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.405 vs BOM:530317: 21.53

Godavari Drugs had a gross margin of 20.38% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Godavari Drugs was -3.60% per year.


Godavari Drugs Gross Margin % Historical Data

The historical data trend for Godavari Drugs's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Godavari Drugs Gross Margin % Chart

Godavari Drugs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.30 19.88 21.26 19.03 19.78

Godavari Drugs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.01 22.88 20.76 22.22 20.38

Competitive Comparison of Godavari Drugs's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Godavari Drugs's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Godavari Drugs's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Godavari Drugs's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Godavari Drugs's Gross Margin % falls into.



Godavari Drugs Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Godavari Drugs's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=315.7 / 1596.248
=(Revenue - Cost of Goods Sold) / Revenue
=(1596.248 - 1280.577) / 1596.248
=19.78 %

Godavari Drugs's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=87.8 / 431.105
=(Revenue - Cost of Goods Sold) / Revenue
=(431.105 - 343.258) / 431.105
=20.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Godavari Drugs  (BOM:530317) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Godavari Drugs had a gross margin of 20.38% for the quarter that ended in Dec. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Godavari Drugs Gross Margin % Related Terms

Thank you for viewing the detailed overview of Godavari Drugs's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Godavari Drugs (BOM:530317) Business Description

Traded in Other Exchanges
N/A
Address
Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003
Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines